Marshall Wace, LLP Profound Medical Corp. Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in Profound Medical Corp. stock. As of the latest transaction made, Marshall Wace, LLP holds 36,216 shares of PROF stock, worth $215,847. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,216
Previous 12,008
201.6%
Holding current value
$215,847
Previous $95,000
185.26%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PROF
# of Institutions
56Shares Held
13.6MCall Options Held
3.9KPut Options Held
1.4K-
Fil LTD Hamilton, D01.8MShares$10.7 Million0.01% of portfolio
-
Gagnon Securities LLC1.65MShares$9.85 Million2.68% of portfolio
-
Letko, Brosseau & Associates Inc Montreal, A81.21MShares$7.22 Million0.18% of portfolio
-
Timelo Investment Management Inc.912KShares$5.43 Million4.82% of portfolio
-
Gagnon Advisors, LLC897KShares$5.34 Million4.87% of portfolio
About Profound Medical Corp.
- Ticker PROF
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,851,300
- Market Cap $124M
- Description
- Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...